SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016929
Filing Date
2023-05-15
Accepted
2023-05-15 08:00:47
Documents
56
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 805539
2 ex31-1.htm EX-31.1 17658
3 ex31-2.htm EX-31.2 17715
4 ex32-1.htm EX-32.1 10501
  Complete submission text file 0001493152-23-016929.txt   4698166

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ghsi-20230331.xsd EX-101.SCH 36506
6 XBRL CALCULATION FILE ghsi-20230331_cal.xml EX-101.CAL 42881
7 XBRL DEFINITION FILE ghsi-20230331_def.xml EX-101.DEF 183546
8 XBRL LABEL FILE ghsi-20230331_lab.xml EX-101.LAB 333557
9 XBRL PRESENTATION FILE ghsi-20230331_pre.xml EX-101.PRE 259741
50 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 694365
Mailing Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098
Business Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098 (800) 873-5141
Guardion Health Sciences, Inc. (Filer) CIK: 0001642375 (see all company filings)

IRS No.: 474428421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38861 | Film No.: 23918493
SIC: 2834 Pharmaceutical Preparations